These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 14623746)

  • 21. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
    Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Pedraza S; Ruiz-Alonso A; Hernández-Martínez AC; Cabello E; Lora D; Pérez-Regadera JF
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):154-159. PubMed ID: 30655026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
    Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
    Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
    Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ
    AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
    Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
    Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities.
    Sigg MB; Steinert H; Grätz K; Hugenin P; Stoeckli S; Eyrich GK
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1022-9. PubMed ID: 12966477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
    Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
    J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
    Huang YT; Ravi Kumar AS
    Nucl Med Commun; 2012 May; 33(5):503-8. PubMed ID: 22262244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
    Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
    Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of [18F]-FDG PET-CT in the management of the head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Cammilleri S; Mundler O; Giovanni A; Zanaret M
    Bull Cancer; 2006 Oct; 93(10):1017-25. PubMed ID: 17074660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
    Stuckensen T; Kovács AF; Adams S; Baum RP
    J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
    Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
    Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
    Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.